Here is a great abstract that helps support this post:
Upregulation of Angiotensin II Type 2 Receptor and Limitation of Myocardial Stunning by Angiotensin II Type 1 Receptor Blockers during Reperfused Myocardial Infarction in the Rat -- Jugdutt and Menon 8 (3): 217 -- Journal of Cardiovascular Pharmacology and Therapeutics
And this article actually suggests how ARBs assist in adipocyte hypotrophy (shrinking fat cells):
Deletion of the Angiotensin Type 2 Receptor (AT2R) Reduces Adipose Cell Size and Protects From Diet-Induced Obesity and Insulin Resistance -- Yvan-Charvet et al. 54 (4): 991 -- Diabetes
Once again, great info YR!